Your Single Source of Truth: The DRHP
Before any company can ask for public money, it must file a Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI). This document is your most important tool. It’s a detailed disclosure of the company's business model,
financial health, management background, and potential risks. Unlike marketing materials, the DRHP is a regulatory document where the company must present a fact-based evaluation of its operations and vulnerabilities. The purpose is to provide transparency and allow investors to make an informed decision before the share price or issue size is even finalised.
Decoding the Financials: Profit vs. Promise
Startup IPOs often sell a story of future growth, but the numbers tell the real story of the present. When reviewing the financial section, look for consistent revenue growth over at least the last three years. However, revenue alone is not enough. Scrutinise the company's profitability. Is it making a net profit, or are losses growing alongside revenue? Also, check the company's debt levels. A high debt-to-equity ratio can be a red flag, especially if the company is not generating positive cash flow from operations to service that debt. While many startups are loss-making, you need to assess if they have a clear and credible path to profitability.
What the Money is For: Growth or Exit?
The 'Objects of the Issue' section in the DRHP explains exactly how the company plans to use the capital raised from the IPO. This is a critical indicator of intent. Ideally, the funds are for growth activities like capacity expansion, entering new markets, or product development. Be more cautious if a large portion of the IPO is an 'Offer for Sale' (OFS), which means existing shareholders, like promoters or early private investors, are selling their stakes. While some selling is normal, an IPO dominated by an OFS might suggest that the early backers are cashing out, leaving retail investors to hold the shares.
The Question of Valuation: What’s a Fair Price?
Valuation is arguably the trickiest part of IPO analysis. A great company can be a bad investment if you pay too much for its shares. Since many startups are not yet profitable, traditional metrics like the Price-to-Earnings (P/E) ratio can be misleading or inapplicable. Instead, compare the company’s valuation to its listed peers based on metrics like Enterprise Value-to-Sales (EV/Sales). If the IPO is priced at a significant premium to its established, profitable competitors, you need to question whether that high price is justified. An excessively high valuation can be a warning sign of hype trumping fundamentals.
Reading Between the Lines: Identifying Red Flags
The 'Risk Factors' section of the DRHP is mandatory reading. Companies must disclose potential threats to their business. Common red flags include heavy dependence on a single large customer, unresolved legal proceedings against the company or its promoters, a complex corporate structure, or a lack of intellectual property protection. Another area to check is the background of the promoters and key management. A strong, experienced leadership team is crucial for navigating the challenges of being a public company.
